Innovative approaches for lung cancer screening and interception
Jianjun Zhang(The University of Texas MD Anderson Cancer Center), Miriam Mérad(Icahn School of Medicine at Mount Sinai), M S Park(Icahn School of Medicine at Mount Sinai), John V. Heymach(The University of Texas MD Anderson Cancer Center), Zhubo Wei(The University of Texas MD Anderson Cancer Center), C. Swanton(The Francis Crick Institute), Elaine Shum(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Torsten Blum(MSB Medical School Berlin), Tej Pandya(University College Hospital), S. M. Dubinett(University of California, Los Angeles), Thomas U. Marron(Icahn School of Medicine at Mount Sinai), Jia Wu(The University of Texas MD Anderson Cancer Center), Hui Li(The University of Texas MD Anderson Cancer Center), Simon Heeke(The University of Texas MD Anderson Cancer Center), Pan-Chyr Yang(National Taiwan University), R. Salehi-Rad(University of California, Los Angeles)
Cited by 3
Related Papers
An inflammatory cytokine signature predicts COVID-19 severity and survival
|Nature Medicine|2020|2.7k
Immunology of COVID-19: Current State of the Science
|Immunity|2020|1.8k
Revised classification of histiocytoses and neoplasms of the macrophage-dendritic cell lineages
|Blood|2016|1.6k